Myriad Genetics (MG)

See the following -

Battle Against Breast Cancer Goes Open Source

Ryan McBride | FierceBiotechIT | July 31, 2013

After a recent U.S. Supreme Court decision shielded Myriad Genetics' genetic data on breast cancer from disclosure, the nonprofit coalition Free the Data! launched a campaign to open troves of molecular information about widespread tumors with the help of big data software outfit Syapse. Read More »

How Big Data Is Taking On Breast Cancer — And Big Biotech

Ki Mae Heussner | GigaOM | July 30, 2013

Now that the Supreme Court has decided that human genes can’t be patented, a group of researchers is using high-tech data science to better understand the genetic mutations associated with breast cancer. Read More »

New Biotech Site Sparks Hope For Cancer Treatments

Staff Writer | The Regional News | October 23, 2013

The latest victory in the Myriad Genetics case in Australia, allowing Myriad Genetics to patent isolated DNA, has sparked new debate over the development of new drugs to treat cancer... Read More »

Self-Preservation Chokes Open Science, Kills The Patient

Pam Baker | FierceBigData | September 9, 2013

Arguably the one area that stands to benefit the most from open and shared data is science. Yet researchers are reluctant to do it. Why? Because the reward model for scientific discovery is chaining them to dollars they can't pocket otherwise. [...] Read More »